glp-1 review article GLP-1-based therapies for diabetes, obesity and beyond The Role of Glucagon-Like Peptide-1

More serious risks include pancreatitis, gallbladder disease, acute kidney injury (particularly with dehydration), hypoglycemia (when combined with insulin or sulfonylureas), and thyroid C-cell tumors in animal studies

For tirzepatide, it explicitly states that the medication is not a reason to discontinue breastfeeding

Consiglio CR, Udartseva O, Ramsey KD, Bush C, Gollnick SO

For additional context on this category, readers may reference related analysis on best peptides for boosting growth hormone published previously

If you are considering or currently using a GLP-1 medication, talking openly with your doctor about cost, insurance coverage and long-term treatment planning is an important part of the conversation.